Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Unsolved problems in neuroscience Stories

2011-10-12 11:30:23

Melatonin, best known for its role in sleep regulation, delayed the onset of symptoms and reduced mortality in a mouse model of Huntington's disease, say researchers at the University of Pittsburgh School of Medicine and Harvard Medical School. Their findings, published today in the Journal of Neuroscience, show for the first time that certain receptors for the hormone reside in the mitochondria, and that there are fewer of them both in affected mice and human brains. Huntington's disease...

2011-10-11 10:05:44

Addressing the earliest stages of Alzheimer's disease, before a patient shows outward signs of cognitive problems, has sometimes been a challenge for physicians and researchers, in part because they have not been using common and specific terms to describe the disease's initial phases. A Mayo Clinic study recommends adding categories to more effectively identify and treat people and give researchers standard definitions to work with. The study is published in this month's issue of the Annals...

2011-10-06 05:00:00

COLORADO SPRINGS, Colo., Oct. 6, 2011 /PRNewswire/ -- Rockies Counseling Center has added the Neurological Assessment Battery (NAB) to its list of psychological services. The NAB is a series of tests that can provide physicians, caregivers and other clinicians with an overview of patient skills, including deficits in memory, executive brain functioning, attention, language and spatial judgments. Adult patients with known or suspected central nervous system disorders complete components...

2011-10-05 15:15:42

Johns Hopkins-led research suggests levels of certain fats in blood might predict rate of cognitive decline A team of scientists, led by Johns Hopkins researchers, say they may have found a way to predict how quickly patients with Alzheimer´s disease (AD) will lose cognitive function by looking at ratios of two fatty compounds in their blood. The finding, they say, could provide useful information to families and caregivers, and might also suggest treatment targets for this...

2011-10-05 05:00:00

LOS ANGELES, Oct. 5, 2011 /PRNewswire/ -- The 6th Annual MDA Tradition of Hope Gala, to be held Oct. 15, 2011 at the Beverly Hilton Hotel, will be a star-studded event bringing more than 500 business and civic leaders together to fight ALS (amyotrophic lateral sclerosis or Lou Gehrig's disease). Expected to raise more than $500,000 for the Muscular Dystrophy Association's Augie's Quest, the funds will help speed research seeking treatments and cures for the devastating disease. MDA's...

2011-10-04 13:35:00

GLEN ALLEN, Va., Oct. 4, 2011 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) reports today the publication of the first peer-reviewed article on the in-vitro and in-vivo activity of anatabine in Alzheimer's Disease. The article is authored by scientists at the Roskamp Institute and is electronically published in the European Journal of Pharmacology (2011 Sept 19). It states that anatabine lowers Alzheimer's A-beta production in-vitro and in-vivo. (Logo:...

2011-10-04 05:54:10

(Ivanhoe Newswire) — Huntington´s disease is a devastating genetic disorder that causes degeneration of nerve cells in the brain. It affects more than 15,000 Americans, and at least 150,000 are at risk of developing the incurable disease.  Now, researchers have identified a transcriptional biomarker that may help in the monitoring of disease activity and in the evaluation of new medications. The research, which is a collaboration between the laboratory of Clemens Scherzer,...

2011-10-03 07:00:00

Corporate partners team up with local ALS Association to form walk teams and increase sponsorship levels. Phoenix, AZ (PRWEB) October 03, 2011 Valley Toyota Dealers, Quicken Loans and Fathead have joined the fight against ALS by sponsoring The Scottsdale Walk to Defeat ALS on Saturday, October 22, 2011 benefitting The ALS Association Arizona Chapter. The walk will be held for the second year at Scottsdale Stadium, where patients along with their families and friends will make a 2.5-mile...

2011-10-03 22:23:47

Laser technique allows detailed view of the early minutes of amyloid aggregate formation -- implications for Alzheimer's disease drug discovery Researchers at the University of Toronto Scarborough (UTSC) and Osaka University applied a new approach to take a close look at amyloid plaque formation, a process that plays important roles in Alzheimer's disease. The technique would greatly aid the development and screening for novel therapeutics that can manipulate the formation of the toxic...

2011-09-30 07:58:00

ANN ARBOR, Mich., Sept. 30, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit (ALS Summit) on Saturday,...